GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Advisors Asset Management Inc.

Advisors Asset Management Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 104,343 shares of the company’s stock after acquiring an additional 6,913 shares during the period. Advisors Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $8,158,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Darwin Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Continuum Advisory LLC grew its holdings in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the last quarter. Bank of Jackson Hole Trust acquired a new position in shares of GE HealthCare Technologies in the fourth quarter worth $32,000. OFI Invest Asset Management purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $34,000. Finally, Flagship Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $34,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.4 %

Shares of GEHC opened at $82.14 on Wednesday. The stock has a 50 day simple moving average of $87.25 and a 200-day simple moving average of $86.10. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The stock has a market cap of $37.56 billion, a PE ratio of 18.97, a PEG ratio of 3.19 and a beta of 1.13. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on GEHC shares. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.